Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Pediatric Blood & Cancer
|
July 21, 2006
Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: a collaborative Children's Oncology Group/National Cancer Institute pilot trial (CCG-1942)
Shana S Jacobs, Linda C Stork, Bruce C Bostrom, et al.
Pediatric Blood & Cancer
|
February 14, 2009
Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS)
V Koneti Rao, Susan Price, Katie Perkins, et al.
Cancer Chemotherapy and Pharmacology
|
April 26, 2001
Plasma pharmacokinetics and cerebrospinal fluid penetration of thioguanine in children with acute lymphoblastic leukemia: a collaborative Pediatric Oncology Branch, NCI, and Children's Cancer Group study
E S Lowe, B J Kitchen, G Erdmann, et al.
Blood
|
April 13, 2006
Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group
Yousif Matloub, Susan Lindemulder, Paul S Gaynon, et al.
Blood Advances
|
June 5, 2019
Excellent long-term survival of children with Down syndrome and standard-risk ALL: a report from the Children's Oncology Group
Yousif Matloub, Karen R Rabin, Lingyun Ji, et al.
Pediatric Blood & Cancer
|
June 14, 2016
Navigating your career path in pediatric hematology/oncology: On and off the beaten track
Patrick A Zweidler-McKay, Mary-Jane Staba Hogan, Rima Jubran, et al.
Leukemia
|
November 15, 2016
Complementary activities of DOT1L and Menin inhibitors in MLL-rearranged leukemia
C Dafflon, V J Craig, H Méreau, et al.
Blood
|
May 13, 2011
Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group
Yousif Matloub, Bruce C Bostrom, Stephen P Hunger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 3, 2018
Dasatinib in Pediatric Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Phase II Trial
Lia Gore, Pamela R Kearns, Maria Lucia de Martino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 12, 2019
Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0331
Kelly W Maloney, Meenakshi Devidas, Cindy Wang, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Pediatric Blood & Cancer
|
July 21, 2006
Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: a collaborative Children's Oncology Group/National Cancer Institute pilot trial (CCG-1942)
Shana S Jacobs, Linda C Stork, Bruce C Bostrom, et al.
Pediatric Blood & Cancer
|
February 14, 2009
Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS)
V Koneti Rao, Susan Price, Katie Perkins, et al.
Cancer Chemotherapy and Pharmacology
|
April 26, 2001
Plasma pharmacokinetics and cerebrospinal fluid penetration of thioguanine in children with acute lymphoblastic leukemia: a collaborative Pediatric Oncology Branch, NCI, and Children's Cancer Group study
E S Lowe, B J Kitchen, G Erdmann, et al.
Blood
|
April 13, 2006
Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group
Yousif Matloub, Susan Lindemulder, Paul S Gaynon, et al.
Blood Advances
|
June 5, 2019
Excellent long-term survival of children with Down syndrome and standard-risk ALL: a report from the Children's Oncology Group
Yousif Matloub, Karen R Rabin, Lingyun Ji, et al.
Pediatric Blood & Cancer
|
June 14, 2016
Navigating your career path in pediatric hematology/oncology: On and off the beaten track
Patrick A Zweidler-McKay, Mary-Jane Staba Hogan, Rima Jubran, et al.
Leukemia
|
November 15, 2016
Complementary activities of DOT1L and Menin inhibitors in MLL-rearranged leukemia
C Dafflon, V J Craig, H Méreau, et al.
Blood
|
May 13, 2011
Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group
Yousif Matloub, Bruce C Bostrom, Stephen P Hunger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 3, 2018
Dasatinib in Pediatric Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Phase II Trial
Lia Gore, Pamela R Kearns, Maria Lucia de Martino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 12, 2019
Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0331
Kelly W Maloney, Meenakshi Devidas, Cindy Wang, et al.
Page
of 5